Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
Clinical trial NCT07253896 · RECRUITING
Trial details
- NCT number
- NCT07253896
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2026-01-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.